Fact CheckerSign in

NCT05203926Completed

Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study

Source: ClinicalTrials.gov · Last updated 24 Jun 2024

Brief summary (registry, in English)

This study aims to further define and characterize imaging findings of possible sacroiliitis in Crohn's Disease patients by recalling subjects who had findings of possible sacroiliitis on prior MRE and assess the natural history and outcome of these cases by using standard magnetic resonance imaging (MRI) and x-ray of the sacroiliac joints.

Status (registry)
Completed
Study type
Interventional
Enrollment
27 (actual)
First submitted
23 Dec 2021
Start date
14 Mar 2022
Primary completion date
4 Nov 2023
Lead sponsor
NYU Langone Health
NCT number
NCT05203926

What you commit to

  • Study type: Interventional
  • Participants enrolled: 27
  • From 14 Mar 2022 to the primary completion date, 4 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of other inflammatory arthritis (e.g. rheumatoid arthritis, systemic lupus erythematosus, gout).

Age

  • History of malignancy \<5 years in remission, (except for non-melanomatous skin cancer).

Other

  • Contraindication to MRI.
  • Inability to comply with study protocol.
  • Critically ill patients.
  • Pregnant patients.
  • Non-English speaking patients (as the questionnaires used in this study are not validated in other languages)

Who the study is looking for

  • Evidence of sacroiliitis on earlier standard of care MRE between 2014 and 2018.
  • Confirmed diagnosis of Crohn's Disease
  • Known HLA-B27 status at time of enrollment and most recent clinical ESR and CRP results from chart (from day of visit or within past 4 weeks of study visit)
  • Adults \>18 years of age

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYU Langone Health
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.